According to a new report from Intel Market Research, the global Systemic Levofloxacin market was valued at USD 486 million in 2024 and is projected to reach USD 707 million by 2034, growing at a steady CAGR of 5.6% during the forecast period (2024-2034). This expansion reflects the critical need for effective broad-spectrum antibiotics against bacterial infections alongside advancements in...